Cargando…

Skin Barrier and Inflammation Genes Associated with Atopic Dermatitis are Regulated by Interleukin-13 and Modulated by Tralokinumab In vitro

Detalles Bibliográficos
Autores principales:	TOLLENAERE, Maxim A. X., LITMAN, Thomas, MOEBUS, Lena, RODRIGUEZ, Elke, STÖLZL, Dora, DRERUP, Katharina, WERFEL, Thomas, SCHMITT, Jochen, NORSGAARD, Hanne, WEIDINGER, Stephan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society for Publication of Acta Dermato-Venereologica 2021
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364260/ https://www.ncbi.nlm.nih.gov/pubmed/33899112 http://dx.doi.org/10.2340/00015555-3810

Ejemplares similares

A new era has begun: Treatment of atopic dermatitis with biologics
por: Stölzl, Dora, et al.
Publicado: (2021)

Status report on the atopic dermatitis registry TREATgermany
por: Siegels, Doreen, et al.
Publicado: (2021)

Tralokinumab Effectively Disrupts the IL-13/IL-13Rα1/IL-4Rα Signaling Complex but Not the IL-13/IL-13Rα2 Complex
por: Tollenaere, Maxim A.X., et al.
Publicado: (2023)

Population Pharmacokinetics of Tralokinumab in Adult Subjects With Moderate to Severe Atopic Dermatitis
por: Soehoel, Anders, et al.
Publicado: (2022)

Atopic dermatitis treated with tralokinumab and upadacitinib combination therapy: A case report
por: Lansang, Rafael Paolo, et al.
Publicado: (2023)

Safety and Efficacy of Tralokinumab in Older Adults With Moderate-to-Severe Atopic Dermatitis: A Secondary Analysis
por: Merola, Joseph F., et al.
Publicado: (2023)

Effects of Early Emollient Use in Children at High Risk of Atopic Dermatitis: A German Pilot Study
por: HARDER, Inken, et al.
Publicado: (2023)

Atopic dermatitis
por: Werfel, Thomas
Publicado: (2011)

Therapeutic Potential of Tralokinumab in the Treatment of Atopic Dermatitis: A Review on the Emerging Clinical Data
por: Kelly, Katherine A, et al.
Publicado: (2022)

Outcomes of COVID-19 and Vaccination in Patients With Moderate to Severe Atopic Dermatitis Treated With Tralokinumab
por: Blauvelt, Andrew, et al.
Publicado: (2022)

Real-World Experience with Tralokinumab in a Patient with Recalcitrant Atopic Dermatitis: A Case Report
por: Moennig, Eva, et al.
Publicado: (2022)

Real-Life Experience of Tralokinumab for the Treatment of Adult Patients with Severe Atopic Dermatitis: A Multicentric Prospective Study
por: De Greef, Axel, et al.
Publicado: (2023)

Autoimmunity (or Not) in Atopic Dermatitis
por: Roesner, Lennart M., et al.
Publicado: (2019)

Autoallergy in atopic dermatitis
por: Hradetzky, Susanne, et al.
Publicado: (2015)

Efficacy and safety of tralokinumab in the treatment of atopic dermatitis: A systematic review and meta-analysis of randomized controlled trials
por: Zhao, Dan-Jie, et al.
Publicado: (2023)

Role of Macrophages in the Pathogenesis of Atopic Dermatitis
por: Kasraie, Sadaf, et al.
Publicado: (2013)

Efficacy and Safety of Tralokinumab in Adolescents With Moderate to Severe Atopic Dermatitis: The Phase 3 ECZTRA 6 Randomized Clinical Trial
por: Paller, Amy S., et al.
Publicado: (2023)

Tralokinumab Efficacy Over 1 Year in Adults with Moderate-to-Severe Atopic Dermatitis: Pooled Data from Two Phase III Trials
por: Simpson, Eric L., et al.
Publicado: (2023)

Tralokinumab Plus Topical Corticosteroids as Needed Provides Progressive and Sustained Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Over a 32-Week Period: An ECZTRA 3 Post Hoc Analysis
por: Silverberg, Jonathan I., et al.
Publicado: (2022)

Itching in Atopic Dermatitis: Patient- and Physician-reported Outcomes in the German Atopic Dermatitis Registry TREATgermany
por: WEISSHAAR, Elke, et al.
Publicado: (2023)

Janus kinase inhibitors for the therapy of atopic dermatitis
por: Traidl, Stephan, et al.
Publicado: (2021)

Tralokinumab plus topical corticosteroids for the treatment of moderate‐to‐severe atopic dermatitis: results from the double‐blind, randomized, multicentre, placebo‐controlled phase III ECZTRA 3 trial
por: Silverberg, J.I., et al.
Publicado: (2021)

Claudin-1 decrease impacts epidermal barrier function in atopic dermatitis lesions dose-dependently
por: Bergmann, Sophia, et al.
Publicado: (2020)

Tralokinumab: First Approval
por: Duggan, Sean
Publicado: (2021)

In-vitro diagnostic in atopic dermatitis: Options and limitations
por: Wichmann, K., et al.
Publicado: (2017)

Correction to: Tralokinumab: First Approval
por: Duggan, Sean
Publicado: (2021)

Correction to: Tralokinumab: First Approval
por: Duggan, Sean
Publicado: (2021)

Difficult to control atopic dermatitis
por: Darsow, Ulf, et al.
Publicado: (2013)

Comparison of Epidermal Barrier Integrity in Adults with Classic Atopic Dermatitis, Atopic Prurigo and Non-Atopic Prurigo Nodularis
por: Fölster-Holst, Regina, et al.
Publicado: (2021)

Safety of tralokinumab in adult patients with moderate‐to‐severe atopic dermatitis: pooled analysis of five randomized, double‐blind, placebo‐controlled phase II and phase III trials
por: Simpson, Eric L., et al.
Publicado: (2022)

Targeting Interleukin 13 for the Treatment of Atopic Dermatitis
por: Lytvyn, Yuliya, et al.
Publicado: (2023)

S2k guideline on diagnosis and treatment of atopic dermatitis — short version
por: Werfel, Thomas, et al.
Publicado: (2016)

Tralokinumab Efficacy and Safety, with or without Topical Corticosteroids, in North American Adults with Moderate-to-Severe Atopic Dermatitis: A Subanalysis of Phase 3 Trials ECZTRA 1, 2, and 3
por: Blauvelt, Andrew, et al.
Publicado: (2022)

Altered Maturation of the Skin Microbiome in Infants with Atopic Dermatitis
por: OLESEN, Caroline M., et al.
Publicado: (2022)

Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)
por: Wollenberg, A., et al.
Publicado: (2020)

Genetic Variation in the Epidermal Transglutaminase Genes Is Not Associated with Atopic Dermatitis
por: Liedén, Agne, et al.
Publicado: (2012)

Handlungsempfehlung zur Therapieumstellung von Immunsuppressiva auf Dupilumab bei Patienten mit atopischer Dermatitis
por: Wohlrab, Johannes, et al.
Publicado: (2020)

Skin Microbiota in Atopic Dermatitis
por: Hrestak, Dora, et al.
Publicado: (2022)

Sézary Syndrome and Atopic Dermatitis: Comparison of Immunological Aspects and Targets
por: Saulite, Ieva, et al.
Publicado: (2016)

Temperature‐controlled laminar airflow in adult atopic dermatitis patients – an observational study
por: Traidl, S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_alavrfnisss25s1in69gjl42qn